BMO Capital Markets downgraded Verve Therapeutics to Market perform, saying Eli Lilly’s agreement to buy the gene-editing specialist leaves limited room for the stock to rise before the transaction is ...

Inc. (NASDAQ:RARE) stock gained 2.2% premarket after the company announced that its experimental treatment for Angelman syndrome received Breakthrough Therapy Designation from the U.S. Food and Drug ...

Evercore ISI raised its rating on advertising-technology firm The Trade Desk (NASDAQ: TTD) to Outperform, saying that the online ad spending is recovering and tha ...

Canada’s economy contracted slightly in April, with real gross domestic product declining 0.1%, down from growing 0.2% in ...